Brief: Egetis Receives Approval In Turkey For Compassionate Use Of Emcitate For MCT8 Deficiency

Egetis Therapeutics AB (publ)

09/09/2021 07:06

Sept 9 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * EGETIS RECEIVES APPROVAL IN TURKEY FOR COMPASSIONATE USE
OF
EMCITATE® FOR MCT8 DEFICIENCY

Source text for Eikon:  ID:nMFN8nw4zz 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))